Adjust Text Size:change font sizechange font sizechange font sizechange font sizechange font sizechange font size

Featured Researcher

Christine Klein

The research of PDF-funded investigator Christine Klein, M.D., into a gene called Parkin, has helped to translate the genetic discoveries in the lab to benefit people with Parkinson’s in the clinic.

Learn More

Find a Clinical Trial


Funding Research & Results

“With the support of PDF, we are able to tackle some of the greatest challenges in Parkinson’s research.” - 2007 IRGP Awardee

Since our founding in 1957, PDF has supported hundreds of research projects and collaborative efforts throughout the world in order to further Parkinson’s science and improve lives for individuals touched by the disease.

PDF's funding philosophy is to empower stakeholders — Parkinson’s scientists, clinicians and other members of the scientific community — to identify novel questions about, and answers to, the puzzle of Parkinson’s. The research program is guided by PDF’s Scientific Advisory Committee, which is headed by Dr. Stanley Fahn and comprised of leading Parkinson's basic, clinical and translational scientists.

We fund research in four distinct ways to find the cause(s) of and a cure for Parkinson’s. One of these is through Center Grants at major universities. Another is encouraging promising young investigators to devote their talents to the study of Parkinson's through mentored fellowships, training opportunities and career development grants. A third is funding talented independent investigators through our International Research Grants Program (IRGP). And through the fourth, PDF is collaborating with other organizations on innovative joint projects.